JP2007505894A5 - - Google Patents

Download PDF

Info

Publication number
JP2007505894A5
JP2007505894A5 JP2006526810A JP2006526810A JP2007505894A5 JP 2007505894 A5 JP2007505894 A5 JP 2007505894A5 JP 2006526810 A JP2006526810 A JP 2006526810A JP 2006526810 A JP2006526810 A JP 2006526810A JP 2007505894 A5 JP2007505894 A5 JP 2007505894A5
Authority
JP
Japan
Prior art keywords
active ingredient
delivery system
drug delivery
oral drug
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006526810A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007505894A (ja
JP5666075B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2004/000192 external-priority patent/WO2005039481A2/en
Publication of JP2007505894A publication Critical patent/JP2007505894A/ja
Publication of JP2007505894A5 publication Critical patent/JP2007505894A5/ja
Application granted granted Critical
Publication of JP5666075B2 publication Critical patent/JP5666075B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

JP2006526810A 2003-09-19 2004-06-30 経口薬送達システム Expired - Lifetime JP5666075B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN987/MUM/2003 2003-09-19
IN987MU2003 2003-09-19
PCT/IN2004/000192 WO2005039481A2 (en) 2003-09-19 2004-06-30 Oral drug delivery system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014210770A Division JP2015038126A (ja) 2003-09-19 2014-10-15 経口薬送達システム

Publications (3)

Publication Number Publication Date
JP2007505894A JP2007505894A (ja) 2007-03-15
JP2007505894A5 true JP2007505894A5 (https=) 2012-06-14
JP5666075B2 JP5666075B2 (ja) 2015-02-12

Family

ID=34509346

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006526810A Expired - Lifetime JP5666075B2 (ja) 2003-09-19 2004-06-30 経口薬送達システム
JP2014210770A Pending JP2015038126A (ja) 2003-09-19 2014-10-15 経口薬送達システム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014210770A Pending JP2015038126A (ja) 2003-09-19 2014-10-15 経口薬送達システム

Country Status (17)

Country Link
US (2) US8163306B2 (https=)
EP (1) EP1663175B1 (https=)
JP (2) JP5666075B2 (https=)
KR (1) KR101164881B1 (https=)
CN (1) CN1856299B (https=)
AP (1) AP2006003602A0 (https=)
AT (1) ATE551051T1 (https=)
AU (2) AU2004283565C1 (https=)
BR (1) BRPI0414305A (https=)
CA (1) CA2543353C (https=)
EA (1) EA013106B1 (https=)
IL (1) IL174396A (https=)
NZ (1) NZ546543A (https=)
PL (2) PL381756A1 (https=)
UA (1) UA85850C2 (https=)
WO (1) WO2005039481A2 (https=)
ZA (1) ZA200602276B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2443632C (en) * 2001-04-10 2011-05-03 Sun Pharmaceutical Industries Limited Timed pulse release composition
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US8163306B2 (en) * 2003-09-19 2012-04-24 Sun Pharma Advanced Research Company Oral drug delivery system
WO2006123357A2 (en) * 2005-02-22 2006-11-23 Sun Pharmaceutical Industries Limited Oral controlled release composition containing levetiracetam
US20080213381A1 (en) * 2005-03-14 2008-09-04 Pharmaceutical Industries Limited Oral Drug Delivery System
US8920837B2 (en) 2005-07-01 2014-12-30 Rubicon Research Private Limited Sustained release dosage form
US8187633B2 (en) * 2005-11-03 2012-05-29 Sun Pharma Advanced Research Company Limited Controlled release coated tablets having prolonged gastric retention
WO2009087663A2 (en) * 2007-11-30 2009-07-16 Sun Pharmaceutical Industries Ltd. Oral controlled release coated tablet
CN102026628A (zh) * 2008-02-15 2011-04-20 太阳医药高级研发有限公司 具有降低崩裂效果的口服控释片剂
US8956654B2 (en) * 2009-06-02 2015-02-17 Dow Global Technologies Llc Sustained release dosage form
US10485770B2 (en) * 2009-12-21 2019-11-26 Aptapharma, Inc. Functionally-coated multilayer tablets
FR2985177B1 (fr) * 2012-01-02 2016-04-01 Oreal Composition cosmetique solide aqueuse comprenant de l'alkylcellulose, au moins deux huiles non volatiles et au moins deux agents tensioactifs
FR2985179B1 (fr) * 2012-01-02 2020-05-15 L'oreal Composition cosmetique aqueuse solide comprenant de l'alkylcellulose, au moins deux huiles non volatiles et au moins deux agents tensioactifs
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
EP3600320A4 (en) 2017-03-31 2020-12-16 Acura Pharmaceuticals, Inc. METHODS AND COMPOSITIONS FOR THE SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL SUBSTANCES
IT201800011123A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione cronotropica di sartani
EP4188366A4 (en) * 2020-07-28 2024-09-04 Novelstar Pharmaceuticals, Inc. NEW EXTENDED RELEASE DOSAGE FORM WITH GASTRIC RETENTION

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2140687A (en) * 1938-02-04 1938-12-20 Claude W Mcqueen Tractor drive take-off
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4693896A (en) * 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
ATE183642T1 (de) * 1991-10-04 1999-09-15 Yoshitomi Pharmaceutical Tablette mit verzögerter freisetzung
DE69425453T2 (de) * 1993-04-23 2001-04-12 Novartis Ag, Basel Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
NZ254765A (en) * 1993-05-15 1997-02-24 Boehringer Mannheim Gmbh Tablet medicament; comprises dichloromethylene diphosphonic acid (clodronic acid) or a pharmaceutically acceptable salt thereof as active ingredient and microcrystalline cellulose as auxiliary
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US20010055613A1 (en) * 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
JP2001055322A (ja) * 1999-08-18 2001-02-27 Tanabe Seiyaku Co Ltd パルス放出型製剤
US6332819B1 (en) * 1999-10-08 2001-12-25 Jerrold K. Emmons Object retrieval device used in water
US6720005B1 (en) * 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
JP4426286B2 (ja) * 2001-07-10 2010-03-03 テバ ファーマシューティカル インダストリーズ リミティド ０次、０次−二相性、上昇型又は下降型薬物放出のための薬物送達システム
ITMI20020515A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
ITMI20020514A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US8163306B2 (en) * 2003-09-19 2012-04-24 Sun Pharma Advanced Research Company Oral drug delivery system

Similar Documents

Publication Publication Date Title
JP2007505894A5 (https=)
FI113941B (fi) Menetelmä pH-herkällä laukaisimella varustettujen, osmoottisten, hajoavien välineiden valmistamiseksi aineen vapauttamiseksi
US8470367B2 (en) Oral drug delivery system
RU2006143540A (ru) Содержащие варденафил лекарственные формы с регулируемым высвобождением действующего вещества
JP2011512349A (ja) 経口放出制御錠剤
CA2323102A1 (en) Monolithic tablet for controlled drug release
KR20130067255A (ko) 경구 투여 형태
EP1239830A2 (en) Dosage forms having a barrier layer to laser ablation
JP2010159301A (ja) 薬物制御放出のための経口用剤形
CA2601800C (en) Oral drug delivery system
US10226428B2 (en) Oral drug delivery system
EP1521570A1 (en) Oral dosage form comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
US20130059004A1 (en) Oral drug delivery system
CA3165394C (en) Soluble rear layer for oral thin film
AU2006209212A1 (en) Controlled release compositions comprising an antipsychotic agent
AU2004261277A1 (en) Permeation-Resistant osmotic engine and dosage form for controlled release of a liquid active agent formulation
CA3165394A1 (en) Soluble rear layer for oral thin film
MXPA06001197A (en) Osmotic engine and dosage form for controlled release of a liquid active agent formulation